Vallon Pharmaceuticals Inc (VLON) Stock
VLON is no longer traded. Vallon Pharmaceuticals was delisted from the Nasdaq in April 2023.
Prices on this page are historical; the last trade was April 21, 2023 at $0.40.
Vallon Pharmaceuticals stock price history
VLON final trading statistics
- Final close
- $0.40
- Final trading day
- Apr 21, 2023
- Market cap at delisting
- $5.39M
- Shares outstanding
- 13.48M
- Final 52-week range
- $0.21 – $2.68
- Avg. volume (final 3 mo.)
- 6,865,574
- All-time high (split-adj.)
- $26426.40 · Sep 2021
- All-time low (split-adj.)
- $587.22 · Dec 2022
- Return since IPO
- -94.7%
- Beta
- -1.15
- Book value / share
- $0.17
- Price / book
- 2.30
Vallon Pharmaceuticals annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2022 | $0.00 | -$7.2M | -$0.80 |
| FY2021 | $0.00 | -$9.4M | -$1.44 |
| FY2020 | $100.0K | -$4.9M | -$0.82 |
| FY2019 | $0.00 | -$3.9M | -$1.03 |
| FY2018 | $0.00 | -$4.3M | -$0.29 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Vallon Pharmaceuticals Inc
As of April 21, 2023, Vallon Pharmaceuticals, Inc. was acquired by GRI Bio, Inc., in a reverse merger transaction. Vallon Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel medications for central nervous system disorders with a focus on abuse-deterrent medications. The company's lead investigational product candidate is ADAIR (Abuse-Deterrent Amphetamine Immediate-Release), an abuse-deterrent oral formulation of immediate-release dextroamphetamine for the treatment of attention-deficit/hyperactivity disorder (ADHD) and narcolepsy. It is also developing ADMIR, an abuse deterrent formulation of methylphenidate for the treatment of ADHD. The company was incorporated in 2018 and is based in Philadelphia, Pennsylvania.
Vallon Pharmaceuticals stock FAQ
What happened to Vallon Pharmaceuticals stock?
Vallon Pharmaceuticals stock was delisted from the Nasdaq. Its final close was $0.40 on April 21, 2023.
Is VLON stock still trading?
No. VLON was delisted from the Nasdaq in April 2023 and no longer trades on a U.S. exchange.
What was the last price of VLON stock?
VLON closed at $0.40 on its final trading day, April 21, 2023, for a market value of about $5.39M.
What were Vallon Pharmaceuticals's revenue and earnings in its last full fiscal year?
Vallon Pharmaceuticals reported revenue of $0.00 and net income of -$7.2M in fiscal 2022, its last full year as a public company.
When did Vallon Pharmaceuticals go public?
Vallon Pharmaceuticals Inc stock began trading on February 10, 2021.